Filipa Farinha

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Controlling cardiovascular risk factors reduces progression of atherosclerosis in a multiethnic cohort of patients with lupus.

Controlling cardiovascular risk factors reduces progression of atherosclerosis in a multiethnic cohort of patients with lupus.

Journal: Lupus science & medicine

Published: February 03, 2026

Real-world safety data of first-line drugs for rheumatoid arthritis: insights from the Portuguese Reuma.pt database.

Real-world safety data of first-line drugs for rheumatoid arthritis: insights from the Portuguese Reuma.pt database.

Journal: ARP rheumatology

Published: January 02, 2026

Unveiling Endotypes in Systemic Lupus Erythematosus Through Multi-Omic Analysis: Insights into Cardiovascular and Renal Complications.

Unveiling Endotypes in Systemic Lupus Erythematosus Through Multi-Omic Analysis: Insights into Cardiovascular and Renal Complications.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: July 01, 2025

Lupus nephritis outcomes - is the picture changing?

Lupus nephritis outcomes - is the picture changing?

Journal: ARP rheumatology

Published: April 01, 2024

Comparing pregnancy outcomes in patients with Systemic Lupus Erythematosus (SLE) and Undifferentiated Connective Tissue Disease (UCTD): a descriptive cohort study.

Comparing pregnancy outcomes in patients with Systemic Lupus Erythematosus (SLE) and Undifferentiated Connective Tissue Disease (UCTD): a descriptive cohort study.

Journal: Revista clinica espanola

Published: March 26, 2024

Anti-SSA Ro52 and anti-Ro60 autoantibodies: association with clinical phenotypes.

Anti-SSA Ro52 and anti-Ro60 autoantibodies: association with clinical phenotypes.

Journal: Clinical and experimental rheumatology

Published: November 11, 2023

Risk of chronic kidney disease in 260 patients with lupus nephritis: analysis of a nationwide multicentre cohort with up to 35 years of follow-up.

Risk of chronic kidney disease in 260 patients with lupus nephritis: analysis of a nationwide multicentre cohort with up to 35 years of follow-up.

Journal: Rheumatology (Oxford, England)

Published: September 12, 2023

Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis.

Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis.

Journal: PloS one

Published: November 29, 2022

A one-point increase in the Damage Index for Antiphospholipid Syndrome (DIAPS) predicts mortality in thrombotic antiphospholipid syndrome.

A one-point increase in the Damage Index for Antiphospholipid Syndrome (DIAPS) predicts mortality in thrombotic antiphospholipid syndrome.

Journal: Clinical and experimental rheumatology

Published: February 28, 2022

Survival analysis of mortality and development of lupus nephritis in patients with systemic lupus erythematosus up to 40 years of follow-up.

Survival analysis of mortality and development of lupus nephritis in patients with systemic lupus erythematosus up to 40 years of follow-up.

Journal: Rheumatology (Oxford, England)

Published: January 28, 2022

Extent of vascular plaque predicts future cardiovascular events in patients with systemic lupus erythematosus.

Extent of vascular plaque predicts future cardiovascular events in patients with systemic lupus erythematosus.

Journal: Rheumatology (Oxford, England)

Published: December 13, 2021

Major determinants of prolonged remission in systemic lupus erythematosus: retrospective study over a 41+ year period.

Major determinants of prolonged remission in systemic lupus erythematosus: retrospective study over a 41+ year period.

Journal: Rheumatology (Oxford, England)

Published: December 03, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026